CEO Joaquin Duato said the spinout will help the healthcare giant focus on medtech areas with higher growth and margins, such ...

While no patients have been harmed, the FDA categorized the action as a Class I recall because of the potential for serious ...

Investment in 2025 has reached $9.9 billion, exceeding the $8.4 billion that was raised through the third quarter last year, ...

The FDA cleared AI and imaging updates for Intuitive’s lung biopsy robot. Elsewhere, Horizon completed the first cataract ...

Executives from Stryker and Johnson & Johnson are on the hunt for deals, despite a turbulent environment, they said at ...

Michelle Tarver, director of the Center for Devices and Radiological Health, and other center officials attended virtually as ...

Six takeaways from the CMS administrator’s appearance at a D.C. think tank Monday — including who’s set to be the next ...

Implementing artificial intelligence requires significant human labor and technical expertise, threatening to create a ...

Capacity at the company's Boston site will increase by 50% as part of a $600 million, 10-year commitment to the U.S.

The sale will leave Owens & Minor focused on a smaller but potentially faster-growing and higher-margin business that ...

At AdvaMed’s annual conference, CEO Scott Whitaker addressed policy issues around tariffs, FDA staff cuts and the ongoing ...

Boston Scientific also foresees future growth in its Watchman business from a planned label expansion and concomitant ...